Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): are neurologists feeling more comfortable to RESTART antiplatelet?
Year: 2019
Type: editorial
Abstract: With an aging global population, the prevalence of chronic atherosclerotic diseases requiring antithrombotic medications has risen steadily (1). The worldwide incidence of haemorrhagic strokes has also been on the rise, as indicated by the Global burden of disease (GBD) study, which revealed a 47% increase in the absolute number of haemorrhagic strokes (2).
Source: Annals of Translational Medicine
Authors: Tarun Girotra, Wuwei Feng
Institutions: University of New Mexico, Duke Medical Center
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2970999082